Concepedia

Robert H. Scannevin

RH

Statistics

Publications

52

Citations

9.8K

H-Index

33

Active since

1996

Affiliations

Biogen (United States)(Current)

Johnson & Johnson (United States)

Johns Hopkins University

Howard Hughes Medical Institute

Harvard University

Robert H. Scannevin is an author at Biogen (United States) specializing in life sciences, neuroscience, and pharmacology.

ORCID

Publications per year

1996–2023

52

Publications

52

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations

, , +14

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

Ralf A. Linker, De-Hyung Lee, Sarah Ryan et al. · Brain · 2011 · 1.2K citations · Full text

, , +17

Phosphorylation of the AMPA Receptor Subunit GluR2 Differentially Regulates Its Interaction with PDZ Domain-Containing Proteins

Hee Jung Chung, Jun Xia, Robert H. Scannevin et al. · Journal of Neuroscience · 2000 · 552 citations · Full text

, , +16

Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway

Robert H. Scannevin, Sowmya Chollate, Mi-Young Jung et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 453 citations

, , +17

A Novel Targeting Signal for Proximal Clustering of the Kv2.1 K+ Channel in Hippocampal Neurons

Seung T. Lim, Dana Antonucci-Durgan, Robert H. Scannevin et al. · Neuron · 2000 · 308 citations · Full text

, , +15

1–5 of 52